BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 21907872)

  • 1. [Physiopathology of rosacea. Redness, telangiectasia, and rosacea].
    Cribier B
    Ann Dermatol Venereol; 2011 Sep; 138 Suppl 2():S129-37. PubMed ID: 21907872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathophysiology of rosacea: redness, telangiectasia, and rosacea.
    Cribier B
    Ann Dermatol Venereol; 2011 Nov; 138 Suppl 3():S184-91. PubMed ID: 22183097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Papulopustular rosacea, skin immunity and Demodex: pityriasis folliculorum as a missing link.
    Forton FM
    J Eur Acad Dermatol Venereol; 2012 Jan; 26(1):19-28. PubMed ID: 22017468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Physiopathology of rosacea].
    Cribier B
    Ann Dermatol Venereol; 2014 Sep; 141 Suppl 2():S158-64. PubMed ID: 25151931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tetracycline actions relevant to rosacea treatment.
    Korting HC; Schöllmann C
    Skin Pharmacol Physiol; 2009; 22(6):287-94. PubMed ID: 19786821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A histological and immunohistological study of vascular and inflammatory changes in rosacea].
    Perrigouard C; Peltre B; Cribier B
    Ann Dermatol Venereol; 2013 Jan; 140(1):21-9. PubMed ID: 23328356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The enigma of rosacea.
    Marks R
    J Dermatolog Treat; 2007; 18(6):326-8. PubMed ID: 18058493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Why is rosacea considered to be an inflammatory disorder? The primary role, clinical relevance, and therapeutic correlations of abnormal innate immune response in rosacea-prone skin.
    Del Rosso JQ; Gallo RL; Kircik L; Thiboutot D; Baldwin HE; Cohen D
    J Drugs Dermatol; 2012 Jun; 11(6):694-700. PubMed ID: 22648215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and laboratory study of rosacea in northern Greece.
    Lazaridou E; Apalla Z; Sotiraki S; Ziakas NG; Fotiadou C; Ioannides D
    J Eur Acad Dermatol Venereol; 2010 Apr; 24(4):410-4. PubMed ID: 19744179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rosacea and the pilosebaceous follicle.
    Powell FC
    Cutis; 2004 Sep; 74(3 Suppl):9-12, 32-4. PubMed ID: 15499752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potential role of microorganisms in the development of rosacea.
    Lazaridou E; Giannopoulou C; Fotiadou C; Vakirlis E; Trigoni A; Ioannides D
    J Dtsch Dermatol Ges; 2011 Jan; 9(1):21-5. PubMed ID: 21059171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rosacea: an update.
    Buechner SA
    Dermatology; 2005; 210(2):100-8. PubMed ID: 15724091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Rosacea].
    Decauchy F; Beauvais L; Meunier L; Meynadier J
    Rev Prat; 1993 Nov; 43(18):2344-8. PubMed ID: 8048975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rosacea: I. Etiology, pathogenesis, and subtype classification.
    Crawford GH; Pelle MT; James WD
    J Am Acad Dermatol; 2004 Sep; 51(3):327-41; quiz 342-4. PubMed ID: 15337973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rosacea: clinical presentation and pathophysiology.
    Diamantis S; Waldorf HA
    J Drugs Dermatol; 2006 Jan; 5(1):8-12. PubMed ID: 16468286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pathophysiology of rosacea.
    Mc Aleer MA; Lacey N; Powell FC
    G Ital Dermatol Venereol; 2009 Dec; 144(6):663-71. PubMed ID: 19907405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rosacea: part I. Introduction, categorization, histology, pathogenesis, and risk factors.
    Two AM; Wu W; Gallo RL; Hata TR
    J Am Acad Dermatol; 2015 May; 72(5):749-58; quiz 759-60. PubMed ID: 25890455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demodicosis: a clinicopathological study.
    Hsu CK; Hsu MM; Lee JY
    J Am Acad Dermatol; 2009 Mar; 60(3):453-62. PubMed ID: 19231642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Etiopathogenesis, classification, and current trends in treatment of rosacea.
    Tisma VS; Basta-Juzbasić A; Dobrić I; Ljubojević S; Mokos ZB
    Acta Dermatovenerol Croat; 2003 Dec; 11(4):236-46. PubMed ID: 14670225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An evaluation of potential correlations between pathophysiologic mechanisms, clinical manifestations, and management of rosacea.
    Del Rosso JQ; Gallo RL; Tanghetti E; Webster G; Thiboutot D
    Cutis; 2013 Mar; 91(3 Suppl):1-8. PubMed ID: 23833998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.